Core Insights - 20/20 BioLabs, Inc. has received over $520,000 in funding from the Maryland Department of Health to support the procurement and administration of its OneTest™ multi-cancer early detection blood test for firefighters [1][2] Funding and Program Details - The funding is part of the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Grant Program, with testing expected to exceed 1,400 firefighters in April or May 2026, representing a ~225% increase in funding compared to the previous year [2] - The Salisbury Fire Department has successfully conducted nearly 300 screenings over the past three years using the OneTest, highlighting the efficiency and satisfaction with the product and service [3] Market and Legislative Context - Maryland is among several states establishing dedicated funding for firefighters to access multi-cancer early detection testing, with more states anticipated to follow suit in the next 24 months [3] - Recent legislation passed by Congress will allow for Medicare coverage of multi-cancer early detection tests starting in 2028, which the company plans to leverage for its OneTest [5] Product and Technology Advantages - 20/20 BioLabs' OneTest combines established protein tumor markers with machine learning AI, offering advantages over DNA-based tests, including cost-effectiveness and better detection rates for early-stage cancers [5] - The OneTest can be administered using pain-free capillary blood collection methods, making it accessible for use at home, workplaces, or retail locations [5][6]